Aprepitant and Piperaquine: Interaction Details

Brand names
Aprepitant
EmendCinvantiAponvie
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

Aprepitant

Brand names
  • Emend
  • Cinvanti
  • Aponvie

Piperaquine

We don't have a drug information page for Piperaquine yet. Have a question about Piperaquine? Ask a pharmacist, free →

What Happens When You Take Aprepitant With Piperaquine

What can happen when they are taken together (rated Major)

Increased or decreased exposure of piperaquine and increased exposure of

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Piperaquine is by CYP3A4, so giving it together with a CYP3A4 can raise its exposure, while a CYP3A4 can lower it. Higher exposure may increase the risk of , and lower exposure may reduce the of piperaquine.

Piperaquine also inhibits CYP3A4, so when it is given with a CYP3A4 substrate, exposure to that substrate may rise. The combination of piperaquine with CYP3A4 is not recommended, whereas caution is advised when piperaquine is used with CYP3A4 or substrates. Because piperaquine has a long , caution is also advised when a CYP3A4 substrate is given for up to 3 months after piperaquine therapy has been discontinued.1

The Aprepitant and Piperaquine Interaction, Explained

Aprepitant (Emend) is used to prevent nausea and vomiting, and piperaquine is an antimalarial. Both are handled by a liver enzyme called . Aprepitant is a moderate blocker of this enzyme, so it could raise piperaquine levels, which may raise the risk of heart rhythm changes (called ). Piperaquine can also slow down how your body clears aprepitant. This is a theoretical concern based on how the drugs work, not on proven problems in patients.

Piperaquine stays in the body for a long time, so the effect can last for weeks to months after the last dose. Please tell your pharmacist and doctor about both medicines. Your care team can manage this with careful timing, dose adjustments if needed, and closer monitoring.

Mechanism: Piperaquine is a and also a CYP3A4 . Aprepitant is a substrate and moderate inhibitor of CYP3A4 (it can also induce CYP3A4 and with repeated dosing). Aprepitant may increase piperaquine exposure (/), raising the risk of . Piperaquine may in turn increase exposure to aprepitant and other CYP3A4 substrates.

  • Evidence: theoretical; onset unspecified; severity rated major.
  • Management: use caution. Consider and electrolyte monitoring, and individualize therapy. Avoid CYP3A4 with piperaquine.
  • Because of piperaquine's long , caution with CYP3A4 substrates may be needed for up to 3 months after stopping it.

See the 1 reference behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Aprepitant and Piperaquine Interact

The likely mechanism

or of -mediated of piperaquine by this drug; inhibition of CYP3A4-mediated metabolism of this drug by piperaquine

How Drug Interactions Work Six short figures, about a minute: how one drug can raise or lower another’s level, or add to or cancel its effect. See how it works 

How to Manage the Aprepitant and Piperaquine Interaction

Keep taking both medicines as prescribed unless your prescriber tells you otherwise. Your care team can manage this by individualizing your doses and may monitor you more closely, especially for heart rhythm effects.

  • Tell your pharmacist and prescriber about every medicine and supplement you take.
  • Because piperaquine lingers in the body, mention it when starting any new medicine for up to 3 months after you finish it.
  • Report fainting, dizziness, or a racing or irregular heartbeat right away.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Aprepitant or Piperaquine need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Aprepitant and Piperaquine: Common Questions

How serious is the Aprepitant and Piperaquine interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Aprepitant and Piperaquine interaction managed?

Keep taking both medicines as prescribed unless your prescriber tells you otherwise. Your care team can manage this by individualizing your doses and may monitor you more closely, especially for heart rhythm effects. Tell your pharmacist and prescriber about every medicine and supplement you take. Because piperaquine lingers in the body, mention it when starting any new medicine for up to 3 months… Management is individual — always follow your own care team's guidance.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

Ask About the Aprepitant and Piperaquine Interaction

Ask in your own words about taking Aprepitant and Piperaquine together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (1)

  1. Product Information: Eurartesim oral film-coated tablets, piperaquine tetraphosphate dihydroartemisinin oral film-coated tablets. Sigma-Tau Industrie Farmaceutiche Riunite S.p.A (per EMA), Rome, Italy, 2012.
Was this write-up helpful?

Other Serious Interactions of Aprepitant and Piperaquine

Also serious with Aprepitant

Also serious with Piperaquine

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Aprepitant

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.